By Tom Murphy, The Associated Press, August 29, 2016
Consumers and politicians have accused the company of price-gouging
Mylan will start selling a cheaper version of its EpiPen after absorbing waves of criticism over a list price for the emergency allergy treatment that has grown to $608 for a two-pack, making it unaffordable for many patients without insurance or with high-deductible coverage.
The drugmaker says it will make available in the next several weeks a generic EpiPen version that is identical to the branded option but will have a list price of $300 for a two-pack.
